Endocalyx Pro, which healthcare practitioners recommend to patients for optimum microvascular health, continues to be studied by researchers for its impacts on multiple conditions and diseases.
Endocalyx Pro has completed, and has ongoing studies, that been running since 2015. These studies are in cell cultures, animals, and in humans. The studies in humans include double-blind placebo designs. These studies are on the following health conditions and diseases:
Functional studies on Endocalyx Pro™ are ongoing and planning to start in the following health conditions and diseases, two of which are COVID-19 studies that include Endocalyx Pro™. Go to Microvascular.com and read the abstracts for these studies:
Sepsis Study Summary: Endocalyx Pro™ in animal sepsis proposal.
Additional studies are being written and in the approval process will be devoted to these conditions:
It takes years to complete studies like these, and even after they are completed it can take months before the peer-reviewed research study is released to the public. As soon as results are available, we will share them publicly at Microvascular.com.
